Bharat Biotech's intranasal Covid-19 vaccine to get DCGI nod soon? Here's what we know
The Drug Controller General of India gave its nod to conduct clinical trials for BBIL's intranasal vaccine as a booster dose.
Full Article
Bharat Biotech's intranasal Covid-19 vaccine to get DCGI nod soon? Here's what we know
DNA
0 shares
2 views
You might like
Related news coverage
-
Intranasal vaccine trial a success, submitted data: Bharat Biotech
IndiaTimes
-
Bharat Biotech's intranasal Covid vaccine proven safe in clinical trials
newKerala.com
-
Bharat Biotech completes clinical development for phase III trials, booster doses for BBV154 intranasal Covid vaccine
newKerala.com
-
Bharat Biotech completes phase III clinical trials for BBV154 intranasal Covid vaccine, says `it`s safe`
Zee News
Advertisement
More coverage
Bharat Biotech submits intranasal vaccine data to drug regulator, says vax safe and immunogenic
Bharat Biotech International Limited (BBIL) on Monday said its intranasal Covid-19 vaccine BBV154 has proved to be safe,..
IndiaTimes
Bharat Biotech expects regulator's nod for intranasal Covid-19 vaccine in August
Bharat Biotech, which is working on an intranasal Covid-19 vaccine candidate is hopeful of getting regulatory licenses this month,..
IndiaTimes